HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Venner Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2012A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07a.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Venner Research Topics

Disease

1Prostatic Neoplasms (Prostate Cancer)
01/2012
1Disease Progression
10/2000
1Adenocarcinoma
10/2000
1Lymphatic Metastasis
10/2000
1Myocarditis (Carditis)
10/2000
1Neoplasm Metastasis (Metastasis)
10/2000
1Spontaneous Remission
10/2000
1Carcinoma (Carcinomatosis)
10/2000
1Renal Cell Carcinoma (Grawitz Tumor)
10/2000
1Ascites
03/2000
1Neoplasms (Cancer)
03/2000

Drug/Important Bio-Agent (IBA)

1epothilone B (EPO906)IBA
01/2012
1Docetaxel (Taxotere)FDA Link
01/2012
1interferon gamma-1bFDA Link
10/2000
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2000
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2000
1Triamcinolone (Aristocort)FDA Link
03/2000
1triamcinolone hexacetonide (Aristospan)FDA Link
03/2000

Therapy/Procedure

1Castration
01/2012
1Nephrectomy
10/2000
1Therapeutics
10/2000
1Aftercare (After-Treatment)
03/2000